| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdbc69d7f5f5e3f7edaf82c3cd36d885 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-502761 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01L3-00 |
| filingDate |
2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6e1e25dcead75ef7d63873ef39972d6 |
| publicationDate |
2018-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180048215-A |
| titleOfInvention |
A method for identifying a subject with cancer for pd-l1 targeted immune therapy with circulating tumor cells |
| abstract |
According to one embodiment of the present invention, the present invention provides a method for discriminating cancer patients for PD-L1 target immunotherapy, which separates PD-L1 expressing CTC using a high-density microchip and detects it using immunofluorescence do. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018190379-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018190382-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022216113-A1 |
| priorityDate |
2016-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |